Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia
Jochen Springer, Anika Tschirner, Kai Hartman, et al.
International Journal of Cancer (2012) Vol. 131, Iss. 9, pp. 2187-2196
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training
T. Scott Bowen, Gerhard Schüler, Volker Adams
Journal of Cachexia Sarcopenia and Muscle (2015) Vol. 6, Iss. 3, pp. 197-207
Open Access | Times Cited: 366
Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia
Johanna Ábrigo, Álvaro A. Elorza, Claudia A. Riedel, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 197
Xanthine oxidoreductase in cancer: more than a differentiation marker
Maria Giulia Battelli, Letizia Polito, Massimo Bortolotti, et al.
Cancer Medicine (2015) Vol. 5, Iss. 3, pp. 546-557
Open Access | Times Cited: 129
Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review
Lluís Campins, M. Valero Camps, Ariadna Riera, et al.
Pharmacology (2016) Vol. 99, Iss. 1-2, pp. 1-8
Open Access | Times Cited: 90
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
Marco Segatto, Raffaella Fittipaldi, Fabrizio Pin, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 89
Catabolic Signaling and Muscle Wasting After Acute Ischemic Stroke in Mice
Jochen Springer, Susanne Schust, Katrin Peske, et al.
Stroke (2014) Vol. 45, Iss. 12, pp. 3675-3683
Open Access | Times Cited: 88
Uric acid and xanthine oxidase in heart failure — Emerging data and therapeutic implications
Wolfram Doehner, Ewa A. Jankowska, Jochen Springer, et al.
International Journal of Cardiology (2015) Vol. 213, pp. 15-19
Closed Access | Times Cited: 76
Reactive oxygen species and calcium signals in skeletal muscle: A crosstalk involved in both normal signaling and disease
Alejandra Espinosa, Carlos Henríquez‐Olguín, Enrique Jaimovich
Cell Calcium (2016) Vol. 60, Iss. 3, pp. 172-179
Closed Access | Times Cited: 64
Synthesis, biological evaluation and molecular docking studies of bis-chalcone derivatives as xanthine oxidase inhibitors and anticancer agents
Serdar Burmaoğlu, Şeyda Özcan, Sevgi Balcıoğlu, et al.
Bioorganic Chemistry (2019) Vol. 91, pp. 103149-103149
Closed Access | Times Cited: 59
Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy
Spencer G. Miller, Paul S. Hafen, Jeffrey J. Brault
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 88-88
Open Access | Times Cited: 56
The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats
Mareike S. Pötsch, Anika Tschirner, Sandra Palus, et al.
Journal of Cachexia Sarcopenia and Muscle (2013) Vol. 5, Iss. 2, pp. 149-158
Open Access | Times Cited: 67
Cancer Cachexia Syndrome: Pathogenesis, Diagnosis, and New Therapeutic Options
Patrizia Mondello, Michael Mian, Carmela Aloisi, et al.
Nutrition and Cancer (2014) Vol. 67, Iss. 1, pp. 12-26
Closed Access | Times Cited: 60
Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation
Vincenzo Musolino, Sandra Palus, Anika Tschirner, et al.
Journal of Cachexia Sarcopenia and Muscle (2016) Vol. 7, Iss. 5, pp. 555-566
Open Access | Times Cited: 56
Redox modulation of muscle mass and function
Mari Carmen Gómez‐Cabrera, Coralie Arc‐Chagnaud, Andrea Salvador‐Pascual, et al.
Redox Biology (2020) Vol. 35, pp. 101531-101531
Open Access | Times Cited: 43
Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs
Shuyi Mi, Liang Gong, Ziqi Sui
Journal of Cancer (2020) Vol. 11, Iss. 17, pp. 5236-5244
Open Access | Times Cited: 42
Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review
Marko Kumrić, Josip A. Borovac, Tina Tičinović Kurir, et al.
Life (2021) Vol. 11, Iss. 1, pp. 53-53
Open Access | Times Cited: 34
TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy
Anna Baumgarten, Claudia Bang, Anika Tschirner, et al.
International Journal of Cardiology (2013) Vol. 168, Iss. 2, pp. 1447-1452
Closed Access | Times Cited: 48
Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia
Sandra Palus, Stephan von Haehling, V FLACH, et al.
International Journal of Cardiology (2013) Vol. 168, Iss. 4, pp. 3412-3418
Closed Access | Times Cited: 48
Reactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases
Lucia Leitner, Rebecca J. Wilson, Zhen Yan, et al.
Antioxidants and Redox Signaling (2016) Vol. 26, Iss. 13, pp. 700-717
Open Access | Times Cited: 42
The Redox Balance: A Target for Interventions Against Muscle Wasting in Cancer Cachexia?
Fabio Penna, Riccardo Ballarò, Paola Costelli
Antioxidants and Redox Signaling (2020) Vol. 33, Iss. 8, pp. 542-558
Open Access | Times Cited: 33
The double faced role of xanthine oxidoreductase in cancer
Man Chen, Linghua Meng
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 7, pp. 1623-1632
Open Access | Times Cited: 32
The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy
Jochen Springer, Anika Tschirner, Kai Hartman, et al.
International Journal of Cardiology (2013) Vol. 168, Iss. 4, pp. 3527-3531
Closed Access | Times Cited: 38
Targeted knock-in mice expressing the oxidase-fixed form of xanthine oxidoreductase favor tumor growth
Teruo Kusano, Driss Ehirchiou, Tomohiro Matsumura, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 35
Influence of cancer cachexia on drug liver metabolism and renal elimination in rats
Katja Trobec, Mojca Kerec Kos, Jurij Trontelj, et al.
Journal of Cachexia Sarcopenia and Muscle (2015) Vol. 6, Iss. 1, pp. 45-52
Open Access | Times Cited: 34
Density Functional Theory, Molecular-Docking Studies and Inhibition Effects of Pharmaceutical Active Ingredients on Xanthine Oxidase
Mustafa Oğuzhan Kaya, Enes Dandan, Tuna Demirci, et al.
Pharmaceutical Chemistry Journal (2025)
Closed Access
Page 1 - Next Page

Scroll to top